Literature DB >> 6407364

Intraoperative fluid management influences carbon dioxide production and respiratory quotient.

M Hagerdal, C B Caldwell, J B Gross.   

Abstract

The authors studied the effects of glucose-containing versus nonglucose-containing solutions for intraoperative fluid management on CO2 production and respiratory quotient (RQ) during the first postoperative hour. Three groups of patients were studied. Patients in Group 1 received normal saline during the operation and first postoperative hour; patients in Groups 2 and 3 received 5% glucose in half normal saline during the operation. This solution was continued through the postoperative period for patients in Group 2, while patients in Group 3 were given normal saline postoperatively. All patients received 500-1000 ml during the first hour and 500 ml/h thereafter. During the first postoperative hour, CO2 production and O2 consumption were measured every 15 min. RQ was significantly higher in Group 2 (0.93 +/- 0.01) than in Group 1 (0.77 +/- 0.01) (means +/- SEM, P less than 0.05). CO2 production was about 20% higher in Group 2 than in Group 1. There were no differences in O2 consumption between Groups 1 and 2. In Group 3, RQ decreased significantly (from 0.97 +/- 0.04 to 0.87 +/- 0.03) during the first postoperative hour but remained higher than in Group 1. The authors conclude that intraoperative administration of glucose-containing solutions increases RQ postoperatively; this effect can be reversed partially by changing to glucose-free solutions in the postanesthetic period.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407364     DOI: 10.1097/00000542-198307000-00009

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  1 in total

1.  Experimental study of efficacy and optimal dose of intraoperative glucose in rabbits under general anesthesia.

Authors:  Hideki Kamuro; Hideto Kodaira; Shun-Ichi Abe; Ryo Ogawa
Journal:  J Anesth       Date:  1996-06       Impact factor: 2.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.